FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer The American Journal of Managed Care
2026
Jeffrey Jensen, MD, reacts to FDA approval of new contraception patch, Gwyn Lo
Jeffrey Jensen, MD, reacts to FDA approval of new contraception patch, Gwyn Lo Contemporary OB/GYN
FDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy
FDA Clears IND for RAG-1C saRNA candidate targeting proliferative vitreoretinopathy Ophthalmology Times Europe